GI Involvement in EDS

Table of Contents

  1. Why the EDS Gut Struggles
  2. Gastroparesis — The Stomach That Won’t Empty
  3. SIBO Overlap
  4. IBS-Type Symptoms & Functional Dyspepsia
  5. GERD, Hiatal Hernia, and PPI Cautions
  6. Organ Prolapse and Hernias
  7. Early Diverticular Disease
  8. The Dysautonomic Gut — POTS Effects
  9. Mast Cell GI Symptoms
  10. Eosinophilic Esophagitis and Gastritis
  11. Median Arcuate Ligament Syndrome (MALS)
  12. Superior Mesenteric Artery Syndrome
  13. Dysmotility Workup
  14. Nutrition Strategies
  15. vEDS and Spontaneous Bowel Rupture
  16. Surgery & Anesthesia Considerations
  17. Building Your Care Team
  18. Key Research Papers
  19. Research Papers
  20. Connections

Why the EDS Gut Struggles

If you have Ehlers-Danlos syndrome and your gut is a daily problem — you are not imagining it, and you are not alone. Studies of hypermobile EDS (hEDS) cohorts consistently find gastrointestinal symptoms in 56–75% of patients. Fikree and colleagues at King’s College London documented this in their 2015 cohort study, and every major EDS clinic since has confirmed it. GI complaints are the second most common reason, after joint pain, that hEDS patients seek medical care.

The reason is mechanical and neurological at once. Your gut is a long tube of smooth muscle wrapped in collagen-rich connective tissue, suspended by collagen-rich ligaments, and coordinated by an autonomic nervous system that also happens to be dysregulated in most EDS patients. When the collagen scaffold is faulty, the tube stretches, sags, and empties unevenly. When the autonomic wiring is off, the tube’s peristaltic rhythm breaks down. You end up with a gut that is simultaneously too floppy and too slow.

This article walks through every layer of that dysfunction — from the stomach that won’t empty to the pelvic floor that won’t hold — and what actually helps.

Gastroparesis — The Stomach That Won’t Empty

Gastroparesis is delayed gastric emptying in the absence of mechanical obstruction. In plain language: your stomach is a bag that has forgotten how to squeeze on schedule. Food sits. You feel full after three bites. An hour later you are nauseous. Two hours later you are still full. By dinner you feel bloated from breakfast.

The classic EDS gastroparesis picture:

The diagnostic gold standard is the 4-hour gastric emptying scintigraphy scan. You eat a standardized egg-white meal labeled with technetium-99m, and a camera tracks how much remains in your stomach at 1, 2, and 4 hours. More than 10% retention at 4 hours is abnormal; more than 35% is moderate; more than 90% is severe. The older 90-minute version of this test is unreliable — insist on the 4-hour protocol.

Treatment That Actually Helps

Meal structure is the first lever, and often the most effective one:

Prokinetics are drugs that nudge the stomach to squeeze. None are perfect, and each has trade-offs:

Non-drug adjuncts that some patients find useful: ginger (250–1000 mg before meals), peppermint oil capsules, acupressure at the P6 (Neiguan) point on the inner wrist, and gastric-emptying-friendly supplements like Iberogast (STW 5).

SIBO Overlap

Small intestinal bacterial overgrowth is so common in hEDS that some motility clinics now screen for it routinely. Studies place SIBO in more than 50% of hEDS patients — several times the general-population rate. The mechanism is mechanical: slow small-bowel transit gives bacteria time to settle and multiply where they don’t belong.

The overlap with gastroparesis is direct — the stomach empties slowly, the small bowel receives intermittent boluses, and the migrating motor complex (the housekeeping wave that sweeps the gut clean between meals) runs weak or absent. Bacteria ferment carbohydrates, produce hydrogen and methane, and you bloat within 30 minutes of eating anything starchy or sweet.

Diagnosis is a 3-hour lactulose or glucose breath test. Treatment begins with rifaximin (550 mg three times daily for 14 days), often combined with neomycin or metronidazole if methane predominates. Relapse is common — which is why EDS patients often cycle through multiple protocols and benefit from prokinetics and elemental diets between rounds.

For a full SIBO workup, see the SIBO overview, the Rifaximin Protocols deep dive, and the Elemental Diet deep dive.

IBS-Type Symptoms & Functional Dyspepsia

Many hEDS patients carry an IBS label from earlier in their medical journey — alternating constipation and diarrhea, bloating that waxes with stress, cramping relieved by a bowel movement. That IBS label is often correct, but it is incomplete: the underlying driver is frequently a combination of dysmotility, SIBO, autonomic dysfunction, and mast-cell reactivity, any of which is individually treatable.

Zeitoun and colleagues (2013) reported that hEDS patients with IBS-type symptoms had measurably abnormal colonic transit and rectal sensation compared to IBS patients without EDS — meaning the gut is not behaving normally and “functional” does not mean “in your head.”

Functional dyspepsia — upper abdominal discomfort, early satiety, postprandial distress — overlaps heavily with mild gastroparesis and is often treated as the same problem. If the 4-hour scintigraphy is normal but symptoms are classic, trial a prokinetic anyway; many patients improve.

Full workup and subtype-directed therapy live on the IBS hub, including the Rome IV subtype breakdown and the IBS Medications Guide.

GERD, Hiatal Hernia, and PPI Cautions

Reflux is nearly universal in hEDS. The lower esophageal sphincter (LES) is a collagen-reinforced ring; when the collagen is faulty, the ring is lax. Stomach contents reflux easily, especially if gastroparesis is also pressurizing the stomach from below. Hiatal hernia — where the upper stomach slides through the diaphragm into the chest — is more common in EDS than in the general population, for the same connective-tissue reason.

Symptoms include heartburn, regurgitation, chronic cough, hoarseness, chest pain that mimics cardiac pain, and dental erosion. Long-standing untreated reflux raises the risk of Barrett’s esophagus — a precancerous change in the esophageal lining. Endoscopic screening every 3–5 years is reasonable if reflux has been ongoing for more than a decade.

PPI Trade-Offs

Proton-pump inhibitors (omeprazole, pantoprazole, esomeprazole) work well for reflux but are not benign long-term. In EDS patients specifically, two concerns loom larger than in the general population:

The pragmatic approach: use a PPI at the lowest effective dose, consider H2 blockers (famotidine) for milder reflux, elevate the head of the bed 6–8 inches, stop eating three hours before lying down, and revisit whether the PPI is still needed every 6–12 months.

Organ Prolapse and Hernias

Collagen holds organs where they belong. When the collagen is faulty, gravity and pressure eventually win. Nelson and colleagues (2015) documented elevated rates of pelvic-organ prolapse, rectal prolapse, and hernia across EDS subtypes.

Pelvic-floor physical therapy is the first-line conservative treatment for prolapse. Surgical repair is reserved for symptomatic cases and should be performed by a surgeon who understands EDS tissue fragility.

Early Diverticular Disease

Diverticula are small out-pouchings of the colon wall where the muscle layer is thin. In the general population, they are rare before age 40. In EDS, earlier-onset diverticular disease is well-documented — sometimes appearing in patients in their 20s and 30s. The mechanism is the same connective-tissue weakness that produces hernias and prolapse, now applied to the colonic wall itself.

Symptoms range from intermittent left-lower-quadrant pain to frank diverticulitis (fever, tenderness, elevated white count). Imaging workup (CT) is identical to non-EDS diverticulitis, but the threshold for considering the diagnosis in a young patient should be lower when EDS is known.

The Dysautonomic Gut — POTS Effects

The gut is an autonomic organ. When the autonomic nervous system misbehaves — as it does in the majority of hEDS patients with POTS — gut motility suffers directly. Chelimsky and colleagues (2014) documented the gut-dysautonomia link in detail.

The POTS-driven gut picture includes:

Volume loading (salt, fluids, compression garments) and POTS-directed therapy often improve gut symptoms as a side effect — which is why the EDS triad needs to be managed as a single system, not three separate problems.

Mast Cell GI Symptoms

Mast cells line the gut from the mouth to the anus. When they degranulate inappropriately — the hallmark of mast cell activation syndrome — the GI tract is often the first place symptoms appear.

Typical MCAS GI picture:

Treatment layers H1 blockers (cetirizine, loratadine, fexofenadine) with H2 blockers (famotidine) and adds oral cromolyn sodium 100–200 mg 15–30 minutes before meals for direct stabilization of gut mast cells. A low-histamine diet and a low-FODMAP diet often overlap and are worth a structured trial under a dietitian’s guidance.

Eosinophilic Esophagitis and Gastritis

Eosinophilic esophagitis (EoE) and eosinophilic gastritis are increasingly recognized in EDS cohorts, particularly in patients who also have atopic disease and MCAS features. Symptoms include food impaction, difficulty swallowing solids, chest pain with eating, and persistent reflux unresponsive to standard PPI therapy. Diagnosis requires endoscopy with multiple biopsies; treatment is usually topical swallowed steroids (budesonide or fluticasone), elimination diets, or biologics (dupilumab) in refractory cases.

Median Arcuate Ligament Syndrome (MALS)

MALS is compression of the celiac artery by the median arcuate ligament of the diaphragm. In people with normal connective tissue, the ligament sits clear of the artery. In EDS, the shifted tissue geometry — combined with weight loss from gastroparesis — allows the ligament to pinch the vessel during expiration.

The classic MALS picture:

Screening is by mesenteric duplex ultrasound with inspiratory/expiratory maneuvers — a noninvasive test that measures celiac-artery flow velocity. Confirmation uses CT or MR angiography. Treatment of symptomatic, imaging-confirmed MALS is laparoscopic release of the median arcuate ligament, sometimes combined with celiac ganglion neurolysis. Outcomes in EDS cohorts are more variable than in the general population, and patient selection matters — MALS anatomy is common, but symptomatic MALS is rarer.

Superior Mesenteric Artery Syndrome

SMA syndrome is compression of the third part of the duodenum between the aorta behind it and the superior mesenteric artery in front of it. Normally, a fat pad keeps the two vessels apart. Weight loss, scoliosis, or loss of abdominal muscle tone (all common in EDS) narrows the angle and pinches the duodenum.

Symptoms: post-prandial epigastric pain, vomiting of partially digested food, bloating that improves lying on the left side or in a knee-chest position, and further weight loss that worsens the anatomy in a vicious cycle. Diagnosis is by CT with oral contrast showing the narrowed aortomesenteric angle. Treatment begins with nutritional rehabilitation (sometimes via NJ tube to restore the fat pad); surgical bypass (duodenojejunostomy) is reserved for refractory cases.

Dysmotility Workup

When symptoms don’t fit neatly into one category, a full motility panel sorts out what is happening where:

Insurance often balks at these studies. Document each symptom and failed empirical therapy in your chart before requesting them — a motility specialist’s referral helps considerably.

Nutrition Strategies

Eating is a project in moderate-to-severe EDS GI disease. The hierarchy of intervention:

Overlap diets matter. A patient with hEDS + MCAS + SIBO may benefit from a combined low-histamine + low-FODMAP approach — but only for limited periods, and with a dietitian’s help, because combined restriction diets are nutritionally risky.

vEDS and Spontaneous Bowel Rupture

Vascular EDS (vEDS) is a separate and more dangerous subtype. The hallmark is fragility of arteries and hollow organs. Spontaneous sigmoid colon rupture is a recognized catastrophic event in vEDS, sometimes with little or no warning beyond abdominal pain.

Any vEDS patient with sudden severe abdominal pain needs urgent imaging (CT) and surgical evaluation. Elective colonoscopy in vEDS is approached with great caution; many vEDS clinicians avoid it unless absolutely necessary because of perforation risk.

Details of vEDS management live on the Classical and Vascular EDS page.

Surgery & Anesthesia Considerations

Any surgery in an EDS patient is higher-stakes than in a non-EDS patient. GI surgery is no exception.

Anesthesia considerations specific to EDS:

Building Your Care Team

No single clinician manages all of this. The realistic roster:

You are the general contractor on this project. Keep a single document with every test result, every medication trial, every flare, and every referral — and bring it to every appointment. The gastroenterologist who sees you for 20 minutes cannot reconstruct a decade of dysfunction; your notes can.

Key Research Papers

Research Papers

For further reading, the following PubMed topic searches return current peer-reviewed work on EDS-related gastrointestinal disease:

  1. Ehlers-Danlos and gastrointestinal involvement
  2. Hypermobile EDS and gastroparesis
  3. Ehlers-Danlos and small intestinal bacterial overgrowth
  4. Ehlers-Danlos and irritable bowel syndrome
  5. Ehlers-Danlos, hiatal hernia, and GERD
  6. Median arcuate ligament syndrome and EDS
  7. Superior mesenteric artery syndrome
  8. Vascular EDS and bowel rupture
  9. Mast cell activation and gastrointestinal disease
  10. POTS and gastrointestinal motility

Connections

Back to Table of Contents